Nano-formulation-based antimicrobial peptides for combating infectious disease.

Nano formulated AMPs for infectious disease.



  • Tamanna Kaundal Ph.D. scholar
  • Dr. Ajay Prakash Associate Professor, Department of Pharmacology
  • Bikash Medhi Professor, Department of Pharmacology


Download data is not yet available.


Metrics Loading ...


AMPs, infectious disease, nanoformulation



How to Cite

Kaundal T, Prakash DA, Bikash Medhi. Nano-formulation-based antimicrobial peptides for combating infectious disease.: Nano formulated AMPs for infectious disease. Scopus Indexed [Internet]. 2023 Nov. 15 [cited 2024 Apr. 20];16(6):7025-9. Available from:


Van Seventer, J.M. and Hochberg, N.S ‘Principles of infectious diseases: Transmission, diagnosis, prevention, and control’, International Encyclopedia of Public Health. 2017, pp. 22–39.

Baker, R.E. et al.,‘Infectious disease in an ERA of global change’, Nature Reviews Microbiology. 2021, 20(4), pp. 193–205.

Salam, M. A., Al-Amin, M. Y., Salam, M. T., Pawar, J. S., Akhter, N., Rabaan, A. A., & Alqumber, M. A. A. Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare (Basel, Switzerland), 2023, 11(13), 1946.

Mba, I. E., & Nweze, E. I. Antimicrobial Peptides Therapy: An Emerging Alternative for Treating Drug-Resistant Bacteria. The Yale journal of biology and medicine, 2022, 95(4), pp 445–463.

Summers WC ‘Virus Infection Encyclopedia of Microbiology’. 2009, pp 546–52.

Fadaka, A. O., Sibuyi, N. R. S., Madiehe, A. M., & Meyer, M. Nanotechnology-Based Delivery Systems for Antimicrobial Peptides. Pharmaceutics, 2021,13(11), 1795.

Alessandra C. Rio et al,. ‘Alternatives to overcoming bacterial resistances: State-of-the-art’, Microbiological Research. 2016, 191, pp 51-80.

Tripathi AK, Singh J, Trivedi R, Ranade P. Shaping the Future of Antimicrobial Therapy: Harnessing the Power of Antimicrobial Peptides in Biomedical Applications. Journal of Functional Biomaterials. 2023; 14(11), 539.

Groo AC, Matougui N, Umerska A, Saulnier P. Reverse micelle-lipid nanocapsules: a novel strategy for drug delivery of the plectasin derivate AP138 antimicrobial peptide. Int J Nanomedicine. 2018 , 13, pp 7565-7574.

Casciaro B, Dutta D, Loffredo MR, Marcheggiani S, McDermott AM, Willcox MD, et al. Esculentin‐1A derived peptides kill pseudomonas aeruginosa biofilm on soft contact lenses and retain antibacterial activity upon immobilization to the lens surface. Peptide Science. 2018, 110(5).

Lionakis, M.S., Drummond, R.A. &Hohl, T.M ‘Immune responses to human fungal pathogens and therapeutic prospects’., Nat Rev Immunol , 2023, 23, pp 433–452

Cuddihy, G., Wasan, E. K., Di, Y., & Wasan, K. M. The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?. Pharmaceutics, 2019, 11(3), 99.

Munita JM, Arias CA ‘Mechanisms of Antibiotic Resistance’, MicrobiolSpectr, 2016, 4(2):

Fisher, M.C., Alastruey-Izquierdo, A., Berman, J. et al.,‘Tackling the emerging threat of antifungal resistance to human health’,Nat Rev Microbiol, 2022, pp 557–571

Ventola CL. ‘The antibiotic resistance crisis: part 1: causes and threats. 2015, pp 277-83.

Wen H, Jung H, Li X ‘Drug Delivery Approaches in Addressing Clinical Pharmacology-Related Issues: Opportunities and Challenges’, AAPS J.2015, 17(6): pp 1327-40.

Patra, J.K., Das, G., Fraceto, L.F. et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 2018, 16, 71

Di Stefano A. Nanotechnology in Targeted Drug Delivery. International journal of molecular sciences. 2023, 24(9), 8194.

Onoue, S., Yamada, S., & Chan, H. K. Nanodrugs: pharmacokinetics and safety. International journal of nanomedicine,2014, 9, pp1025–1037.

Luo Y, Song Y. ‘Mechanism of Antimicrobial Peptides: Antimicrobial, Anti-Inflammatory, and Antibiofilm Activities’. Int J Mol Sci.2021, 22(21):11401.

Jeevanandam J. ‘Nano-formulations of drugs: Recent developments, impact, and challenges’, Biochimie, 2016, pp 128–129.

De Jong WH, Borm PJ. ‘Drug delivery and nanoparticles: applications and hazards’. Int J Nanomedicine.2008, 3(2), pp 133-49.

Stepanova, M. et al. ‘Polypeptide-based systems: From synthesis to application in drug delivery’, Pharmaceutics, 2023, 15(11), 2641.

Reinhardt, A., & Neundorf, I. Design and Application of Antimicrobial Peptide Conjugates. International journal of molecular sciences,2016, 17(5), 701.

Begines, B., Ortiz, T., Pérez-Aranda, M., Martínez, G., Merinero, M., Argüelles-Arias, F., & Alcudia, A. Polymeric Nanoparticles for Drug Delivery: Recent Developments and Future Prospects. Nanomaterials (Basel, Switzerland), 2023, 10(7), 1403.

Browne K et al., ‘A New Era of Antibiotics: The Clinical Potential of Antimicrobial Peptides’. Int J MolSci, 2020, 24;21(19), 7047.

Zhang QY et al., ‘Antimicrobial peptides: mechanism of action, activity and clinical potential. Mil Med Res. 2021, 9;8(1), 48.